Table 3.

Tumors Treated With Excision

	Tumor Characteristics					Care Characteristics
Patient Age, y	Clinical Subtype or Descriptor	Type	Additional Histologic Features	Body Location	Diameter, mm	Training Level of Treating Clinician	Curettage Before Excision	Size of Margins, mm	Margins Clear of Tumor?	Annual Visits to Dermatology Clinic, Mean No.	Time After Treatment to Detection of Recurrence, mo
77	None specified	BCC	Infiltrative, keratinizing	Cheek, not in H-zone	4	Resident	Yes	Not specified	Yes	1.9	30
82	None specified	BCC	Nodular	Anterior mid-chest	10	Resident	Yes	3	Yes	2.9	79
58	Nodular	BCC	Superficial, nodular	Temple, H-zone	4	Resident	Not described	Not specified	Yes	1.5	76
66a	Nodular	BCC	Superficial, nodular	Shoulder	15	Resident	Yes	3	Yes	3.1	3
63	Nodular	BCC	Nodular	Mid-back	13	Resident	Not described	Not specified	Yes	2.6	51
77	Nodular	BCC	Infiltrative, nodular	Temple, H-zone	Not specified	Resident	Yes	3	Yes	2.4	17
72	None specified	BCC	Nodular	Temple, H-zone	6	Resident	Yes	Not specified	Yes	1.3	46
82	None specified	BCC	Nodular, infiltrative	Back	13	Resident	Yes	Not specified	Yes	3	9
72	None specified	BCC	Superficial	Forehead, H-zone	2	Resident	Yes	Not specified	Yes	1.7	51
83	Papule	SCC	In situ	Ear helix, H-zone	3	Resident	Yes	3	Yes	1.5	15
80	None specifie	SCC	In situ	Forehead, H-zone	14	Resident	Yes	3	Yes	3.3	62
54	Indistinct margins	SCC	Invasive	Pubic area	25	Resident	Yes	3	Yes	0.1	90
50	Papule	SCC	In situ, acantholytic	Temple, H-zone	8	Resident	Yes	Not specified	Yes	2.3	27
				Tumor That Possibly Recurred After Excision (No Histologic Confirmation)
50	None specified	SCC	Invasive	Anterior chest	12	Resident	Not described	Not specified	Yes	2.5	Examined at 104 mo

Abbreviations: BCC, basal cell carcinoma; ED&C, electrodessication and curettage; NMSC, nonmelanoma skin cancer; SCC, squamous cell carcinoma.

^aPatient was described in the chart has having human immunodeficiency virus/AIDS.